|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.88 USD | -3.10% |
|
+4.48% | +26.27% |
| Market Cap | 3.88B 3.39B 3.13B 2.92B 5.51B 367B 5.61B 37.58B 14.59B 181B 14.57B 14.24B 630B | P/E 2026 * |
-8.39x | P/E 2027 * | -9.14x |
|---|---|---|---|---|---|
| Enterprise Value | 3.26B 2.85B 2.63B 2.45B 4.62B 308B 4.71B 31.56B 12.25B 152B 12.23B 11.96B 529B | EV / Sales 2026 * |
38.3x | EV / Sales 2027 * | 38.9x |
| Free-Float |
70.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -3.15% | ||
| 1 week | +4.48% | ||
| Current month | -2.40% | ||
| 1 month | +17.22% | ||
| 3 months | +37.77% | ||
| 6 months | +29.20% | ||
| Current year | +26.27% |
| 1 week | 28 |  | 31.74 |
| 1 month | 21.84 | | 31.74 |
| Current year | 18.52 | | 31.74 |
| 1 year | 8.03 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 01/05/2015 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 01/05/2015 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 01/12/2017 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 18/09/2017 |
Yasunori Kaneko
BRD | Director/Board Member | 71 | 01/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06 | Sell | Founder | -6,431 | 0.0051% | ||
| 11/06 | Free | Director | 22,600 | 0.0180% | ||
| 11/06 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.10% | +4.48% | +259.93% | +47.21% | 3.88B | |
| +2.77% | +6.17% | -0.53% | +5.97% | 47.18B | |
| +0.29% | +10.73% | +409.60% | +600.67% | 39.82B | |
| +6.25% | +10.93% | +26.62% | -6.86% | 32.25B | |
| +2.43% | +4.65% | +18.29% | +60.35% | 31.68B | |
| +0.69% | +8.72% | +14.80% | +30.86% | 24.59B | |
| -1.52% | +11.07% | - | - | 16.57B | |
| +3.89% | +7.28% | +71.34% | +130.13% | 15.12B | |
| -0.20% | +2.09% | +12.57% | +17.48% | 13.69B | |
| -1.08% | +2.76% | +96.87% | +91.41% | 13.1B | |
| Average | +1.01% | +7.57% | +101.05% | +108.58% | 23.79B | |
| Weighted average by Cap. | +1.83% | +7.44% | +97.66% | +136.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.06M 74.45M 68.73M 64.11M 121M 8.04B 123M 824M 320M 3.97B 320M 312M 13.83B | 93.06M 81.45M 75.19M 70.14M 132M 8.8B 135M 902M 350M 4.34B 350M 342M 15.13B |
| Net income | -456M -399M -369M -344M -648M -43.15B -660M -4.42B -1.72B -21.29B -1.71B -1.68B -74.18B | -431M -377M -348M -324M -611M -40.71B -622M -4.17B -1.62B -20.09B -1.62B -1.58B -69.98B |
| Net Debt | -621M -544M -502M -468M -882M -58.75B -898M -6.02B -2.34B -28.99B -2.33B -2.28B -101B | -259M -227M -210M -195M -368M -24.52B -375M -2.51B -976M -12.1B -974M -953M -42.16B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | USD 30.00 | -2.69% | 288,300 |
| 30/06/26 | USD 30.83 | -0.80% | 1,344,884 |
| 29/06/26 | USD 31.08 | +0.26% | 1,565,332 |
| 26/06/26 | USD 31.00 | +2.48% | 4,352,591 |
| 25/06/26 | USD 30.25 | +5.03% | 2,509,348 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
